OBT has entered a multi-year partnership with Roche to discover antibody-based therapeutics for cancer treatment.

Brainomix entered the US market in 2023 having gained several FDA clearances for modules within its stroke care platform.

Recent data shows that 75,000 businesses and 56,000 jobs in Alabama benefit from using TikTok, with 45% saying the platform ...

Oxford BioTherapeutics inks multi-year collaboration with Roche to discover novel targets for antibody-based therapeutics to treat cancer: Oxford, UK Thursday, March 20, 2025, 17: ...

Brainomix, a company pioneering AI-powered imaging tools in stroke and lung fibrosis, today announced the completion of a ...

Britain’s foreign intelligence agency has launched a search for its next chief and the current officeholder has suggested ...

Democratic voters want the party to take a firmer line in Congress, even if it leads to gridlock, according to a new poll.

In April 2024, Barinthus Bio announced topline results from the Phase 1b/2 APOLLO dose-ranging trial (also known as HPV001) ...

TECELRA® launch momentum accelerating – 10 patients apheresed in Q1 2025 and 3 in 2024; 20 ATCs available; all manufacturing and supply goals ...

The Report: Abu Dhabi 2025 will examine the key factors shaping the emirate’s economic growth, with a particular focus on the ...